Cynata Therapeutics
(ASX) CYP
Cynata Therapeutics Financials at a Glance
Market Cap
$70.05M
Revenue (TTM)
$1.66M
Net Income (TTM)
$17.26M
EPS (TTM)
$-0.04
P/E Ratio
-8.02
Dividend
$0.00
Beta (Volatility)
0.28 (Low)
Dividend
$0.00
Beta (Volatility)
0.28 (Low)
Price
$0.29
Volume
192,353
Open
$0.29
Price
$0.29
Volume
192,353
Open
$0.29
Previous Close
$0.29
Daily Range
$0.28 - $0.29
52-Week Range
$0.14 - $0.43
Dividend
$0.00
Beta (Volatility)
0.28 (Low)
Price
$0.29
Volume
192,353
Open
$0.29
Previous Close
$0.29
Daily Range
$0.28 - $0.29
52-Week Range
$0.14 - $0.43
CYP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cynata Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Kilian Kelly, PhD
Website
www.cynata.comHeadquarters
Cremorne, VIC 3121, AU
CYP Financials
Key Financial Metrics (TTM)
Gross Margin
3%
Operating Margin
170%
Net Income Margin
99%
Return on Equity
-113%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
-12.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$70.05M
Shares Outstanding
237.45M
Volume
192.35K
Short Interest
0.00%
Avg. Volume
243.40K
Financials (TTM)
Gross Profit
$1.89M
Operating Income
$8.12M
EBITDA
$9.33M
Operating Cash Flow
$8.72M
Capital Expenditure
$50.00K
Free Cash Flow
$8.77M
Cash & ST Invst.
$5.05M
Total Debt
$0.00
Cynata Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$130.25K
-105.4%
Gross Margin
0.00%
N/A
Market Cap
$70.05M
N/A
Market Cap/Employee
N/A
N/A
Employees
0
N/A
Net Income
$2.66M
+41.4%
EBITDA
$4.30M
+35.9%
Quarterly Fundamentals
Net Cash
$2.59M
-76.8%
Accounts Receivable
$69.61K
-9.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.86%
N/A
Return on Invested Capital
-4.26%
N/A
Free Cash Flow
$5.74M
+18.0%
Operating Cash Flow
$5.79M
+17.3%